Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients

Journal of Proteomics

Volumn 76, Issue , 2012, Pages 239-250

  Chaichompoo, Porntip ^a,b   Kumya, Panida ^a   Khowawisetsut, Ladawan ^a   Chiangjong, Wararat ^a,b   Chaiyarit, Sakdithep ^a,b   Pongsakul, Nutkridta ^a,b   Sirithanaratanakul, Noppadol ^a   Fucharoen, Suthat ^b   Thongboonkerd, Visith ^a,b   Pattanapanyasat, Kovit ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Microparticle; Oxidative stress; Platelet; Procoagulant; Proteome; Thalassemia

Indexed keywords

APO B100 PRECURSOR; APOLIPOPROTEIN E; ASCC3 PROTEIN; CHAIN A CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE GLYCINE PROLINE; CHAIN A HEAT SHOCK 70KD PROTEIN; CHAIN A MOLECULAR BASIS FOR THE RECOGNITION OF PHOSPHORYLATED AND PHOSPHOACETYLATED HISTONEH3 BY 14 3 3; CHAIN A THREE DIMENSIONAL STRUCTURE OF DIMERIC HUMAN RECOMBINANT MACROPHAGE COLONY STIMULATING FACTOR; CHAIN A X RAY STRUCTURE OF THE COMPLEX BETWEEN CARBONIC ANHYDRASE I AND THE PHOSPHONATE ANTIVIRAL DRUG FOSCARNET; CYCLOPHILIN A; CYTOCHROME P450; FIBRIN BETA; GLUTATHIONE; GUANINE NUCLEOTIDE BINDING PROTEIN G SUBUNIT ALPHA; HEAT SHOCK PROTEIN 90; HEMOGLOBIN; HEMOGLOBIN E; HEMOGLOBIN MU; HSP90AA1 PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; N ETHYLMALEIMIDE SENSITIVE FACTOR ATTACHMENT PROTEIN ALPHA; PANTOTHENATE KINASE 3 ISOFORM CRA B; PEROXIREDOXIN 6; PHOSPHATIDYLSERINE; PROTEIN; REACTIVE OXYGEN METABOLITE; RNA POLYMERASE II 140 KDA SUBUNIT; TRABECULIN ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; WWOX DELTA5 8;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD CLOTTING; CELL MEMBRANE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; ERYTHROCYTE COUNT; FLOW CYTOMETRY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; THROMBOCYTE COUNT; THROMBOCYTE FREE PLASMA MICROPARTICLE; TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; BETA-THALASSEMIA; BLOOD PROTEINS; CELL-DERIVED MICROPARTICLES; FEMALE; HEMOGLOBIN E; HEMOGLOBINURIA; HUMANS; MALE; PLASMA; PROTEOME; PROTEOMICS; THROMBOEMBOLISM;

EID: 84869871106     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.06.004     Document Type: Article

References (35)

1. Weatherall D.J. Pathophysiology of thalassaemia. Baillieres Clin Haematol 1998, 11:127-146.
2. Schrier S.L. Pathophysiology of thalassemia. Curr Opin Hematol 2002, 9:123-126.
3. Fucharoen S., Winichagoon P. Thalassemia and abnormal hemoglobin. Int J Hematol 2002, 76(Suppl. 2):83-89.
4. Wagner G.M., Chiu D.T., Yee M.C., Lubin B.H. Red cell vesiculation-a common membrane physiologic event. J Lab Clin Med 1986, 108:315-324.
5. Olivieri N.F. The beta-thalassemias. N Engl J Med 1999, 341:99-109.
6. Zwaal R.F., Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997, 89:1121-1132.
7. Kuypers F.A., de Jong K. The role of phosphatidylserine in recognition and removal of erythrocytes. Cell Mol Biol (Noisy-le-Grand) 2004, 50:147-158.
8. Rund D., Rachmilewitz E. Beta-thalassemia. N Engl J Med 2005, 353:1135-1146.
9. Helley D., Eldor A., Girot R., Ducrocq R., Guillin M.C., Bezeaud A. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia. Thromb Haemost 1996, 76:322-327.
10. Chen S., Eldor A., Barshtein G., Zhang S., Goldfarb A., Rachmilewitz E., et al. Enhanced aggregability of red blood cells of beta-thalassemia major patients. Am J Physiol 1996, 270:H1951-H1956.
11. Hugel B., Martinez M.C., Kunzelmann C., Freyssinet J.M. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005, 20:22-27.
12. Morel O., Toti F., Hugel B., Freyssinet J.M. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004, 11:156-164.
13. Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis 2006, 36:182-187.
14. Combes V., Simon A.C., Grau G.E., Arnoux D., Camoin L., Sabatier F., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999, 104:93-102.
15. Eldor A., Rachmilewitz E.A. The hypercoagulable state in thalassemia. Blood 2002, 99:36-43.
16. VanWijk M.J., VanBavel E., Sturk A., Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003, 59:277-287.
17. Pattanapanyasat K., Gonwong S., Chaichompoo P., Noulsri E., Lerdwana S., Sukapirom K., et al. Activated platelet-derived microparticles in thalassaemia. Br J Haematol 2007, 136:462-471.
18. Freyssinet J.M., Toti F. Formation of procoagulant microparticles and properties. Thromb Res 2010, 125(Suppl. 1):S46-S48.
19. Rank A., Nieuwland R., Delker R., Kohler A., Toth B., Pihusch V., et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res 2010, 126:e255-e259.
20. Shai E, Rosa I, Parguina AF, Motahedeh S, Varon D, Garcia A. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics in press.
21. Jy W., Horstman L.L., Jimenez J.J., Ahn Y.S., Biro E., Nieuwland R., et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2:1842-1851.
22. Amer J., Ghoti H., Rachmilewitz E., Koren A., Levin C., Fibach E. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 2006, 132:108-113.
23. Ostergaard O., Nielsen C.T., Iversen L.V., Jacobsen S., Tanassi J.T., Heegaard N.H. Quantitative proteome profiling of normal human circulating microparticles. J Proteome Res 2012, 11:2154-2163.
24. Ahn Y.S., Jy W., Jimenez J.J., Horstman L.L. More on: cellular microparticles: what are they bad or good for?. J Thromb Haemost 2004, 2:1215-1216.
25. Pattanapanyasat K., Noulsri E., Fucharoen S., Lerdwana S., Lamchiagdhase P., Siritanaratkul N., et al. Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clin Cytom 2004, 57:23-31.
26. Bhattacharya D., Saha S., Basu S., Chakravarty S., Chakravarty A., Banerjee D., et al. Differential regulation of redox proteins and chaperones in HbEbeta-thalassemia erythrocyte proteome. Proteomics Clin Appl 2010, 4:480-488.
27. Chakrabarti A., Bhattacharya D., Basu A., Basu S., Saha S., Halder S. Differential expression of red cell proteins in hemoglobinopathy. Proteomics Clin Appl 2011, 5:98-108.
28. Jin M., Drwal G., Bourgeois T., Saltz J., Wu H.M. Distinct proteome features of plasma microparticles. Proteomics 2005, 5:1940-1952.
29. Stuhlmeier K.M., Kao J.J., Wallbrandt P., Lindberg M., Hammarstrom B., Broell H., et al. Antioxidant protein 2 prevents methemoglobin formation in erythrocyte hemolysates. Eur J Biochem 2003, 270:334-341.
30. Economou-Petersen E., Aessopos A., Kladi A., Flevari P., Karabatsos F., Fragodimitri C., et al. Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. Blood 1998, 92:3455-3459.
31. Lemons P.P., Chen D., Bernstein A.M., Bennett M.K., Whiteheart S.W. Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery. Blood 1997, 90:1490-1500.
32. Andreeva A.V., Kutuzov M.A., Vaiskunaite R., Profirovic J., Meigs T.E., Predescu S., et al. G alpha12 interaction with alphaSNAP induces VE-cadherin localization at endothelial junctions and regulates barrier function. J Biol Chem 2005, 280:30376-30383.
33. Brass L.F., Hoxie J.A., Manning D.R. Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb Haemost 1993, 70:217-223.
34. Stuart M.J. Platelet dysfunction in homozygous beta-thalassemia. Pediatr Res 1979, 13:1345-1349.
35. Yoshida M., Xia Y. Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase. J Biol Chem 2003, 278:36953-36958.